Navigation Links
Carnegie Mellon team makes sequestration recommendations
Date:7/23/2009

PITTSBURGHCarbon capture and sequestration (CCS) technology, which captures carbon dioxide from power plants and safely disposes of it deep underground, will not meet its full potential in the United States without new federal regulations that create a uniform regulatory environment.

This is the conclusion of a set of four policy briefs just released by the CSSReg project led by M. Granger Morgan, head of Carnegie Mellon University's Department of Engineering and Public Policy.

"At the moment, there is a patchwork of different rules across the U.S. and a great deal of legal uncertainty," Morgan said. "We need a clear way for CCS projects to obtain the right to inject carbon dioxide into appropriate geological formations and a strategy for safely addressing long-term stewardship once an injection project ends."

Morgan and his colleagues believe that without a safe and cost-effective way to use CCS, as part of a broader strategy for CO2 emissions control, there is no way the country will be able to achieve the reductions in future CO2 emissions that Congress and the Obama administration are now proposing.

The policy briefs, available from http://www.CCSReg.org, describe changes to federal law and agency rules needed to overcome regulatory and legal barriers to large-scale deployment of carbon sequestration.

The CCSReg project is supported by a $1.85-million grant from the New York-based Doris Duke Charitable Foundation (DDCF) with additional support from the National Science Foundation (NSF). In addition to investigators at Carnegie Mellon, the project team involves experts at the University of Minnesota, the Vermont Law School and the Washington, D.C.- based law firm of Van Ness Feldman.

While Morgan and his colleagues argue that a general framework for "performance-based regulation" should be established today, they believe the U.S. must build and gain experience with several commercial-scale facilities before finalizing many
'/>"/>

Contact: Chriss Swaney
swaney@andrew.cmu.edu
412-268-5776
Carnegie Mellon University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Carnegie Mellons Kris Matyjaszewski recieves EPAs Presidential Green Chemistry Challenge Award
2. Carnegie Mellon researchers apply new statistical test
3. Carnegies Donald Brown receives lifetime achievement award from Society for Developmental Biology
4. Carnegies Doug Koshland elected Fellow of the American Academy of Microbiology
5. Carnegies Joe Berry elected Fellow of the American Geophysical Union
6. Carnegies Arthur Grossman receives Gilbert Morgan Smith medal
7. Carnegie Mellon to unveil new sequestration plan
8. Carnegies Field and Koshland Elected AAAS Fellows
9. Carnegie Mellon developing automated systems to enable precision farming of apples, oranges
10. Carnegie Mellons Philip LeDuc participates in think tank forums
11. Carnegie Mellon to receive $900,000 from EPA for brownfields research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to ... State of Washington,s Department of Licensing, in ... central issuance system for driver,s licenses and identification cards to ... and development will start in January 2015, with enrollment and ...
(Date:1/22/2015)... 2015  BellBrook Labs, a leader in high throughput ... of a TR-FRET (time resolved Forster resonance energy ... a high throughput screening assay for glycosyltransferases and ... for sensitive detection of hundreds of human and ...
(Date:1/22/2015)... Jan. 21, 2015  Analyst Report Issued by Small Cap IR. ... showed that planet-wide, transactions at merchants on the leading payment ... number of credit, debit, and prepaid cards reached 6.54 billion.  ... of fraudulent card usage in 2012, and credit and debit ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
... fossilized footprints found at Dinosaur Cove in Victoria, Australia, ... making them the oldest known bird tracks in Australia. ... analysis of the footprints led by Anthony Martin, a ... trace fossils, which include tracks, burrows and nests. The ...
... Griffith University led study has made the surprising ... for South East Queenslanders from the Irukandji jellyfish. ... have conducted a series of climate change simulation ... the Irukandji, is likely to establish breeding populations ...
... A new analysis has found that the presence of ... papillary thyroid cancer tumors suggests a likelihood of recurrence ... early online in CANCER , a peer-reviewed journal ... blood levels of the genetic material after surgery may ...
Cached Biology News:Tell-tale toes point to oldest-known fossil bird tracks from Australia 2Tell-tale toes point to oldest-known fossil bird tracks from Australia 3Irukandji threat to southern waters 2Measuring segments of genetic material may help predict and monitor recurrence after thyroid cancer 2
(Date:2/26/2015)... -- S&P Capital IQ (MHFI) announced today that it ... Therapeutics Holdings Inc . MabVax Therapeutics ... focused on the development of vaccine and antibody-based therapies ... cancer. MabVax has discovered a pipeline of human monoclonal ... by patients who have been immunized against targeted cancers. ...
(Date:2/26/2015)... 2015   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... Chief Executive Officer of Regulus, will present a company ... Annual Healthcare Conference on Wednesday, March 4, 2015 at ... the Boston Marriott Copley Place.  The ...
(Date:2/26/2015)... 26, 2015  NuGene International, Inc. ("NuGene") (OTCQB: ... skin and hair rejuvenation, has announced that it ... record for investor relations and strategic communications. ... sales and diversification strategies – and we need ... shareholders," stated Ali Kharazmi CEO of NuGene when ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Innovation ... are emerging from unexpected parts of the world ... From agriculture to manufacturing to health care, ... and environmental realities and socio-political trends shake the ... the key ingredient for CEOs to survive the ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 2NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 3One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2
... When pregnant women need medications, there is often ... drugs are clearly recognized to cause birth defects (thalidomide ... as safe, surprisingly little is known about most drugs, ... Informatics Program (CHIP) have created a preclinical model for ...
... Jan. 4, 2011 Neogen Corporation (Nasdaq: NEOG ... quarter of FY 2011, which ended Nov. 30, increased 33% ... quarter rose to $6,110,000, or $0.26 per share, compared to ... 25% to $43,931,000, compared to the prior year,s $35,251,000. Year-to-date ...
... YORK, Jan. 4, 2011 ... market research report is available ... Product-Development-Opportunities-And-Business-Expansion-Strategies-For-Instrument-And-Reagent-Suppliers.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire title=,The 2011 Clinical ... Europe, Japan: Product Development Opportunities ...
Cached Biology Technology:Model Predicts a Drug's Likelihood of Causing Birth Defects 2Model Predicts a Drug's Likelihood of Causing Birth Defects 3Neogen Reports 33% Increase in Net Income 2Neogen Reports 33% Increase in Net Income 3Neogen Reports 33% Increase in Net Income 4Neogen Reports 33% Increase in Net Income 5Reportlinker Adds The 2011 Clinical Chemistry And Immunodiagnostics Markets US, Europe, Japan: Product Development Opportunities And Business Expansion Strategies For Instrument And Reagent Suppliers 2
Anti-GOSR2 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunocytochemistry, Immunoprecipitation, Western Blot...
Mouse monoclonal [4A2.2] to SLC6A4 ( Abpromise for all tested applications). entrezGeneID: 6532 SwissProtID: P31645...
... shaking and rocking for maximal fluid movement. This ... stainless steel or acrylic platform, it is perfect ... The platform angle is easily adjusted from 0 ... and rotation speed of platform is adjusted from ...
Anti-DNA Polymerase a, Human Description: 50 l Research Focus: cancer & cell proliferation Storage: 4C Shipping Temperature: 4C...
Biology Products: